|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Adaptive Biotechnologies Corporation
|
170.27 Million USD
|
99.793%
|
|
IO Biotech, Inc.
|
- USD
|
-Infinity%
|
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
16.745%
|
|
Organovo Holdings, Inc.
|
109 Thousand USD
|
-223.853%
|
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-56.051%
|
|
Tonix Pharmaceuticals Holding Corp.
|
7.76 Million USD
|
95.456%
|
|
Aadi Bioscience, Inc.
|
24.35 Million USD
|
98.551%
|
|
Savara Inc.
|
- USD
|
-Infinity%
|
|
Aerovate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Rocket Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
ZyVersa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Soligenix, Inc.
|
839.35 Thousand USD
|
57.944%
|
|
Aptose Biosciences Inc.
|
- USD
|
-Infinity%
|
|
NKGen Biotech, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Century Therapeutics, Inc.
|
2.23 Million USD
|
84.206%
|
|
Eterna Therapeutics Inc.
|
68 Thousand USD
|
-419.118%
|
|
Precision BioSciences, Inc.
|
48.72 Million USD
|
99.276%
|
|
Axsome Therapeutics, Inc.
|
270.6 Million USD
|
99.87%
|
|
Kura Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
86.102%
|
|
Dyadic International, Inc.
|
2.89 Million USD
|
87.823%
|
|
TScan Therapeutics, Inc.
|
21.04 Million USD
|
98.323%
|
|
IDEAYA Biosciences, Inc.
|
23.38 Million USD
|
98.49%
|
|
CytomX Therapeutics, Inc.
|
101.21 Million USD
|
99.651%
|
|
Autolus Therapeutics plc
|
1.69 Million USD
|
79.211%
|
|
Eton Pharmaceuticals, Inc.
|
31.64 Million USD
|
98.884%
|
|
EyePoint Pharmaceuticals, Inc.
|
46.01 Million USD
|
99.233%
|
|
GRI Bio, Inc.
|
21.76 Million USD
|
98.378%
|
|
Tenaya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
IGM Biosciences, Inc.
|
2.13 Million USD
|
83.427%
|
|
Heron Therapeutics, Inc.
|
127.04 Million USD
|
99.722%
|
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
84.234%
|
|
Entero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Opthea Limited
|
261.85 Thousand USD
|
-34.805%
|
|
X4 Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Atara Biotherapeutics, Inc.
|
8.57 Million USD
|
95.882%
|
|
Pliant Therapeutics, Inc.
|
1.58 Million USD
|
77.658%
|
|
Ligand Pharmaceuticals Incorporated
|
131.31 Million USD
|
99.731%
|
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
|
Ovid Therapeutics Inc.
|
391.69 Thousand USD
|
9.879%
|
|
Sorrento Therapeutics, Inc.
|
62.83 Million USD
|
99.438%
|
|
Acelyrin, Inc.
|
- USD
|
-Infinity%
|
|
Centessa Pharmaceuticals plc
|
6.85 Million USD
|
94.849%
|
|
Hepion Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Arcturus Therapeutics Holdings Inc.
|
157.74 Million USD
|
99.776%
|
|
Syros Pharmaceuticals, Inc.
|
9.93 Million USD
|
96.447%
|
|
ADMA Biologics, Inc.
|
258.21 Million USD
|
99.863%
|
|
PureTech Health plc
|
3.33 Million USD
|
89.399%
|
|
Oncternal Therapeutics, Inc.
|
785 Thousand USD
|
55.032%
|
|
FibroBiologics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
55.985%
|
|
Kymera Therapeutics, Inc.
|
78.59 Million USD
|
99.551%
|
|
Synaptogenix, Inc.
|
- USD
|
-Infinity%
|
|
Tiziana Life Sciences Ltd
|
- USD
|
-Infinity%
|
|
ChromaDex Corporation
|
83.57 Million USD
|
99.578%
|
|
Inhibikase Therapeutics, Inc.
|
260.5 Thousand USD
|
-35.509%
|
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Exelixis, Inc.
|
1.83 Billion USD
|
99.981%
|
|
Akebia Therapeutics, Inc.
|
194.62 Million USD
|
99.819%
|
|
Better Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Nurix Therapeutics, Inc.
|
76.98 Million USD
|
99.541%
|
|
Apellis Pharmaceuticals, Inc.
|
396.59 Million USD
|
99.911%
|
|
Sangamo Therapeutics, Inc.
|
176.23 Million USD
|
99.8%
|
|
Seer, Inc.
|
15.18 Million USD
|
97.675%
|
|
Aridis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
LAVA Therapeutics N.V.
|
6.76 Million USD
|
94.785%
|
|
Gritstone bio, Inc.
|
1.33 Million USD
|
73.479%
|
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Avid Bioservices, Inc.
|
139.91 Million USD
|
99.748%
|
|
Insmed Incorporated
|
305.2 Million USD
|
99.884%
|
|
Panbela Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Avalo Therapeutics, Inc.
|
1.92 Million USD
|
81.653%
|
|
Fate Therapeutics, Inc.
|
63.53 Million USD
|
99.444%
|
|
MediWound Ltd.
|
18.68 Million USD
|
98.111%
|
|
BioXcel Therapeutics, Inc.
|
1.38 Million USD
|
74.42%
|
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.582%
|
|
OmniAb, Inc.
|
34.16 Million USD
|
98.967%
|
|
Seres Therapeutics, Inc.
|
126.32 Million USD
|
99.721%
|
|
Zai Lab Limited
|
266.71 Million USD
|
99.868%
|
|
Revance Therapeutics, Inc.
|
234.04 Million USD
|
99.849%
|
|
Tarsus Pharmaceuticals, Inc.
|
17.44 Million USD
|
97.977%
|
|
Veracyte, Inc.
|
361.05 Million USD
|
99.902%
|
|
Abeona Therapeutics Inc.
|
3.5 Million USD
|
89.914%
|
|
FibroGen, Inc.
|
147.75 Million USD
|
99.761%
|
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
ContextLogic Inc.
|
287 Million USD
|
99.877%
|
|
Intensity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Adial Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
HOOKIPA Pharma Inc.
|
20.12 Million USD
|
98.246%
|
|
Jazz Pharmaceuticals plc
|
3.83 Billion USD
|
99.991%
|
|
Entrada Therapeutics, Inc.
|
129.01 Million USD
|
99.726%
|
|
Cyclacel Pharmaceuticals, Inc.
|
420 Thousand USD
|
15.952%
|
|
ImmuCell Corporation
|
17.47 Million USD
|
97.98%
|
|
Fortrea Holdings Inc.
|
3.1 Billion USD
|
99.989%
|
|
KalVista Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Foghorn Therapeutics Inc.
|
34.15 Million USD
|
98.966%
|
|
Ultragenyx Pharmaceutical Inc.
|
434.24 Million USD
|
99.919%
|
|
Theravance Biopharma, Inc.
|
57.42 Million USD
|
99.385%
|
|
Metagenomi, Inc. Common Stock
|
44.75 Million USD
|
99.211%
|
|
Vaxxinity, Inc.
|
- USD
|
-Infinity%
|
|
BioCryst Pharmaceuticals, Inc.
|
331.41 Million USD
|
99.893%
|
|
Gain Therapeutics, Inc.
|
55.18 Thousand USD
|
-539.725%
|
|
Creative Medical Technology Holdings, Inc.
|
9000.00 USD
|
-3822.222%
|
|
Marker Therapeutics, Inc.
|
3.31 Million USD
|
89.339%
|
|
CASI Pharmaceuticals, Inc.
|
33.87 Million USD
|
98.958%
|
|
Senti Biosciences, Inc.
|
2.56 Million USD
|
86.216%
|
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
-142.112%
|
|
Apollomics, Inc.
|
821 Thousand USD
|
57.004%
|
|
89bio, Inc.
|
- USD
|
-Infinity%
|
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
99.853%
|
|
TransCode Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
RAPT Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Ardelyx, Inc.
|
124.45 Million USD
|
99.716%
|
|
Pluri Inc.
|
326 Thousand USD
|
-8.282%
|
|
Prothena Corporation plc
|
91.37 Million USD
|
99.614%
|
|
Pulmatrix, Inc.
|
7.29 Million USD
|
95.163%
|
|
Celularity Inc.
|
22.77 Million USD
|
98.45%
|
|
MeiraGTx Holdings plc
|
14.01 Million USD
|
97.482%
|
|
Omeros Corporation
|
- USD
|
-Infinity%
|
|
Ainos, Inc.
|
122.11 Thousand USD
|
-189.079%
|
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
|
Mesoblast Limited
|
5.9 Million USD
|
94.019%
|
|
Cocrystal Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Cidara Therapeutics, Inc.
|
63.9 Million USD
|
99.448%
|
|
Blueprint Medicines Corporation
|
249.38 Million USD
|
99.858%
|
|
Cabaletta Bio, Inc.
|
- USD
|
-Infinity%
|
|
Summit Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Alaunos Therapeutics, Inc.
|
5000.00 USD
|
-6960.0%
|
|
Scholar Rock Holding Corporation
|
- USD
|
-Infinity%
|
|
Intellia Therapeutics, Inc.
|
36.27 Million USD
|
99.027%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
4.99 Million USD
|
92.934%
|
|
Cytokinetics, Incorporated
|
7.53 Million USD
|
95.312%
|
|
Eloxx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Nutriband Inc.
|
2.08 Million USD
|
83.072%
|
|
Protara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Roivant Sciences Ltd.
|
124.79 Million USD
|
99.717%
|
|
Evogene Ltd.
|
5.64 Million USD
|
93.741%
|
|
Applied Therapeutics, Inc.
|
9.99 Million USD
|
96.468%
|
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BridgeBio Pharma, Inc.
|
9.3 Million USD
|
96.206%
|
|
BioLineRx Ltd.
|
4.8 Million USD
|
92.646%
|
|
Atai Life Sciences N.V.
|
314 Thousand USD
|
-12.42%
|
|
VistaGen Therapeutics, Inc.
|
1.06 Million USD
|
66.823%
|
|
Aurinia Pharmaceuticals Inc.
|
175.51 Million USD
|
99.799%
|
|
MediciNova, Inc.
|
1 Million USD
|
64.7%
|
|
Praxis Precision Medicines, Inc.
|
2.44 Million USD
|
85.574%
|
|
MiMedx Group, Inc.
|
321.47 Million USD
|
99.89%
|
|
PTC Therapeutics, Inc.
|
937.82 Million USD
|
99.962%
|
|
Cullinan Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Syndax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
4D Molecular Therapeutics, Inc.
|
20.72 Million USD
|
98.297%
|
|
Dyne Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
270.25 Million USD
|
99.869%
|
|
Ventyx Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Allakos Inc.
|
- USD
|
-Infinity%
|
|
Fulcrum Therapeutics, Inc.
|
2.8 Million USD
|
87.415%
|
|
Corcept Therapeutics Incorporated
|
482.37 Million USD
|
99.927%
|
|
BioAtla, Inc.
|
- USD
|
-Infinity%
|
|
Allogene Therapeutics, Inc.
|
95 Thousand USD
|
-271.579%
|
|
Larimar Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Precigen, Inc.
|
6.22 Million USD
|
94.329%
|
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
|
XOMA Corporation
|
4.75 Million USD
|
92.581%
|
|
Kezar Life Sciences, Inc.
|
7 Million USD
|
94.957%
|
|
Incyte Corporation
|
3.69 Billion USD
|
99.99%
|
|
Cara Therapeutics, Inc.
|
20.96 Million USD
|
98.316%
|
|
Aligos Therapeutics, Inc.
|
15.52 Million USD
|
97.727%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
CRISPR Therapeutics AG
|
371.2 Million USD
|
99.905%
|
|
Akero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
EyeGate Pharmaceuticals, Inc.
|
12.05 Thousand USD
|
-2827.274%
|
|
UroGen Pharma Ltd.
|
82.71 Million USD
|
99.573%
|
|
Sutro Biopharma, Inc.
|
153.73 Million USD
|
99.77%
|
|
ZIVO Bioscience, Inc.
|
27.65 Thousand USD
|
-1176.673%
|
|
Lisata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Stoke Therapeutics, Inc.
|
8.78 Million USD
|
95.979%
|
|
Chimerix, Inc.
|
324 Thousand USD
|
-8.951%
|
|
Outlook Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
60 Degrees Pharmaceuticals, Inc.
|
253.57 Thousand USD
|
-39.21%
|
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
99.554%
|
|
Aprea Therapeutics, Inc.
|
583.23 Thousand USD
|
39.475%
|
|
Portage Biotech Inc.
|
- USD
|
-Infinity%
|
|
OncoCyte Corporation
|
1.5 Million USD
|
76.514%
|
|
Qualigen Therapeutics, Inc.
|
5.2 Million USD
|
93.218%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Processa Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Purple Biotech Ltd.
|
- USD
|
-Infinity%
|
|
NextCure, Inc.
|
- USD
|
-Infinity%
|
|
ProMIS Neurosciences, Inc.
|
- USD
|
-Infinity%
|
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Generation Bio Co.
|
5.9 Million USD
|
94.021%
|
|
Neumora Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Xeris Biopharma Holdings, Inc.
|
163.91 Million USD
|
99.785%
|
|
TRACON Pharmaceuticals, Inc.
|
12.04 Million USD
|
97.069%
|
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Novavax, Inc.
|
983.7 Million USD
|
99.964%
|
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Curis, Inc.
|
10.02 Million USD
|
96.478%
|
|
Daré Bioscience, Inc.
|
2.8 Million USD
|
87.428%
|
|
Titan Pharmaceuticals, Inc.
|
184 Thousand USD
|
-91.848%
|
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Bicycle Therapeutics plc
|
26.97 Million USD
|
98.691%
|
|
BeiGene, Ltd.
|
2.45 Billion USD
|
99.986%
|
|
Kiromic BioPharma, Inc.
|
- USD
|
-Infinity%
|
|
Alector, Inc.
|
97.06 Million USD
|
99.636%
|
|
Protagonist Therapeutics, Inc.
|
60 Million USD
|
99.412%
|
|
Erasca, Inc.
|
- USD
|
-Infinity%
|
|
Checkpoint Therapeutics, Inc.
|
103 Thousand USD
|
-242.718%
|
|
Aura Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Viracta Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Chemomab Therapeutics Ltd.
|
- USD
|
-Infinity%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Pieris Pharmaceuticals, Inc.
|
42.81 Million USD
|
99.175%
|
|
BioMarin Pharmaceutical Inc.
|
2.41 Billion USD
|
99.985%
|
|
Histogen Inc.
|
3.76 Million USD
|
90.634%
|
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.582%
|
|
Avidity Biosciences, Inc.
|
9.56 Million USD
|
96.308%
|
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
-171.538%
|
|
Galecto, Inc.
|
- USD
|
-Infinity%
|
|
InMed Pharmaceuticals Inc.
|
4.59 Million USD
|
92.322%
|
|
Phathom Pharmaceuticals, Inc.
|
682 Thousand USD
|
48.24%
|
|
Molecular Templates, Inc.
|
57.3 Million USD
|
99.384%
|
|
PDS Biotechnology Corporation
|
- USD
|
-Infinity%
|
|
Amylyx Pharmaceuticals, Inc.
|
380.78 Million USD
|
99.907%
|
|
Amarin Corporation plc
|
306.91 Million USD
|
99.885%
|
|
TG Therapeutics, Inc.
|
233.66 Million USD
|
99.849%
|
|
Aptevo Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Celldex Therapeutics, Inc.
|
6.88 Million USD
|
94.871%
|
|
Cogent Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Onconetix, Inc.
|
58.46 Thousand USD
|
-503.78%
|
|
MacroGenics, Inc.
|
58.74 Million USD
|
99.399%
|
|
Y-mAbs Therapeutics, Inc.
|
84.81 Million USD
|
99.584%
|
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
98.147%
|
|
Adagene Inc.
|
18.11 Million USD
|
98.051%
|
|
Inhibrx Biosciences, Inc.
|
1.8 Million USD
|
80.389%
|
|
Cartesian Therapeutics, Inc.
|
26 Million USD
|
98.643%
|
|
Voyager Therapeutics, Inc.
|
250 Million USD
|
99.859%
|
|
SciSparc Ltd.
|
2.87 Million USD
|
87.739%
|
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Minerva Neurosciences, Inc.
|
- USD
|
-Infinity%
|
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Black Diamond Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Arcutis Biotherapeutics, Inc.
|
59.6 Million USD
|
99.408%
|
|
Relay Therapeutics, Inc.
|
25.54 Million USD
|
98.618%
|
|
Alnylam Pharmaceuticals, Inc.
|
1.82 Billion USD
|
99.981%
|
|
Psyence Biomedical Ltd.
|
- USD
|
-Infinity%
|
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
2seventy bio, Inc.
|
100.38 Million USD
|
99.648%
|
|
Clene Inc.
|
654 Thousand USD
|
46.024%
|
|
Boundless Bio, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
147.8 Thousand USD
|
-138.828%
|
|
Arbutus Biopharma Corporation
|
18.14 Million USD
|
98.054%
|
|
Scopus BioPharma Inc.
|
- USD
|
-Infinity%
|
|
Absci Corporation
|
5.71 Million USD
|
93.827%
|
|
XBiotech Inc.
|
- USD
|
-Infinity%
|
|
ALX Oncology Holdings Inc.
|
- USD
|
-Infinity%
|
|
Lyra Therapeutics, Inc.
|
1.55 Million USD
|
77.343%
|
|
Entera Bio Ltd.
|
- USD
|
-Infinity%
|
|
Trevena, Inc.
|
3.12 Million USD
|
88.704%
|
|
Adaptimmune Therapeutics plc
|
60.28 Million USD
|
99.414%
|
|
Caribou Biosciences, Inc.
|
34.47 Million USD
|
98.976%
|
|
INmune Bio, Inc.
|
155 Thousand USD
|
-127.742%
|
|
Citius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Tyra Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
|
Unity Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
Tenax Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Jaguar Health, Inc.
|
9.76 Million USD
|
96.384%
|
|
Clearside Biomedical, Inc.
|
8.22 Million USD
|
95.709%
|
|
NexImmune, Inc.
|
- USD
|
-Infinity%
|
|
Connect Biopharma Holdings Limited
|
- USD
|
-Infinity%
|
|
Clearmind Medicine Inc.
|
- USD
|
-Infinity%
|
|
Coeptis Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Kronos Bio, Inc.
|
6.28 Million USD
|
94.386%
|
|
Innoviva, Inc.
|
310.46 Million USD
|
99.886%
|
|
Coherus BioSciences, Inc.
|
257.24 Million USD
|
99.863%
|
|
Regeneron Pharmaceuticals, Inc.
|
13.11 Billion USD
|
99.997%
|
|
Bolt Biotherapeutics, Inc.
|
7.87 Million USD
|
95.518%
|
|
Verastem, Inc.
|
- USD
|
-Infinity%
|
|
ProKidney Corp.
|
- USD
|
-Infinity%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Imunon, Inc.
|
- USD
|
-Infinity%
|
|
Viking Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Statera Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
ImmunityBio, Inc.
|
622 Thousand USD
|
43.248%
|
|
Korro Bio, Inc.
|
- USD
|
-Infinity%
|
|
Travere Therapeutics, Inc.
|
145.23 Million USD
|
99.757%
|
|
Kineta, Inc.
|
5.44 Million USD
|
93.513%
|
|
Catalyst Pharmaceuticals, Inc.
|
398.2 Million USD
|
99.911%
|
|
Capricor Therapeutics, Inc.
|
25.17 Million USD
|
98.598%
|
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
Keros Therapeutics, Inc.
|
151 Thousand USD
|
-133.775%
|
|
Celularity Inc.
|
22.77 Million USD
|
98.45%
|
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
91.204%
|
|
CalciMedica, Inc.
|
- USD
|
-Infinity%
|
|
Cibus, Inc.
|
1.81 Million USD
|
80.572%
|
|
C4 Therapeutics, Inc.
|
20.75 Million USD
|
98.299%
|
|
Marinus Pharmaceuticals, Inc.
|
30.98 Million USD
|
98.861%
|
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Kodiak Sciences Inc.
|
- USD
|
-Infinity%
|
|
Sana Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
Annexon, Inc.
|
- USD
|
-Infinity%
|
|
Adverum Biotechnologies, Inc.
|
3.6 Million USD
|
90.194%
|
|
Assembly Biosciences, Inc.
|
7.16 Million USD
|
95.072%
|
|
Elicio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Moderna, Inc.
|
6.84 Billion USD
|
99.995%
|
|
Vigil Neuroscience, Inc.
|
- USD
|
-Infinity%
|
|
Ionis Pharmaceuticals, Inc.
|
787.64 Million USD
|
99.955%
|
|
Vor Biopharma Inc.
|
- USD
|
-Infinity%
|
|
Eyenovia, Inc.
|
3787.00 USD
|
-9221.363%
|
|
DiaMedica Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Puma Biotechnology, Inc.
|
235.63 Million USD
|
99.85%
|
|
Monte Rosa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Wave Life Sciences Ltd.
|
113.3 Million USD
|
99.688%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
ACADIA Pharmaceuticals Inc.
|
726.43 Million USD
|
99.951%
|
|
Immunocore Holdings plc
|
249.42 Million USD
|
99.858%
|
|
Tango Therapeutics, Inc.
|
36.52 Million USD
|
99.034%
|
|
Galectin Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Alkermes plc
|
1.66 Billion USD
|
99.979%
|
|
Arcellx, Inc.
|
110.31 Million USD
|
99.68%
|
|
Renovaro Biosciences Inc.
|
- USD
|
-Infinity%
|
|
Zentalis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Sagimet Biosciences Inc.
|
2 Million USD
|
82.35%
|
|
Regulus Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-1968.561%
|
|
Moolec Science SA
|
905.04 Thousand USD
|
60.997%
|
|
Biomea Fusion, Inc.
|
- USD
|
-Infinity%
|
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
|
Geron Corporation
|
237 Thousand USD
|
-48.945%
|
|
Mereo BioPharma Group plc
|
10 Million USD
|
96.47%
|
|
Verrica Pharmaceuticals Inc.
|
5.12 Million USD
|
93.111%
|
|
Royalty Pharma plc
|
2.35 Billion USD
|
99.985%
|
|
Atea Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Greenwich LifeSciences, Inc.
|
- USD
|
-Infinity%
|
|
Calithera Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
TFF Pharmaceuticals, Inc.
|
733.87 Thousand USD
|
51.899%
|
|
Mersana Therapeutics, Inc.
|
36.85 Million USD
|
99.042%
|
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
|
Structure Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
|
Genelux Corporation
|
170 Thousand USD
|
-107.647%
|
|
ESSA Pharma Inc.
|
- USD
|
-Infinity%
|
|
Notable Labs, Ltd.
|
310 Thousand USD
|
-13.871%
|
|
Alzamend Neuro, Inc.
|
- USD
|
-Infinity%
|
|
Mustang Bio, Inc.
|
- USD
|
-Infinity%
|
|
Immunovant, Inc.
|
- USD
|
-Infinity%
|
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
|
Vericel Corporation
|
197.51 Million USD
|
99.821%
|
|
Halozyme Therapeutics, Inc.
|
829.25 Million USD
|
99.957%
|
|
Akari Therapeutics, Plc
|
- USD
|
-Infinity%
|
|
Acasti Pharma Inc.
|
- USD
|
-Infinity%
|
|
MiNK Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vaxcyte, Inc.
|
- USD
|
-Infinity%
|
|
Orgenesis Inc.
|
530 Thousand USD
|
33.396%
|
|
Spruce Biosciences, Inc.
|
10.08 Million USD
|
96.501%
|
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
GH Research PLC
|
- USD
|
-Infinity%
|
|
Tempest Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
PepGen Inc.
|
- USD
|
-Infinity%
|
|
Moleculin Biotech, Inc.
|
- USD
|
-Infinity%
|
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Silo Pharma, Inc.
|
72.1 Thousand USD
|
-389.584%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Belite Bio, Inc
|
- USD
|
-Infinity%
|
|
Pharming Group N.V.
|
245.31 Million USD
|
99.856%
|
|
XOMA Corporation
|
4.75 Million USD
|
92.581%
|
|
Reneo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Bionomics Limited
|
- USD
|
-Infinity%
|
|
Xencor, Inc.
|
168.33 Million USD
|
99.79%
|
|
Replimune Group, Inc.
|
- USD
|
-Infinity%
|
|
Pyxis Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Cassava Sciences, Inc.
|
- USD
|
-Infinity%
|
|
Vanda Pharmaceuticals Inc.
|
192.64 Million USD
|
99.817%
|
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
|
Turnstone Biologics Corp.
|
19.3 Million USD
|
98.172%
|
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
|
MEI Pharma, Inc.
|
65.29 Million USD
|
99.459%
|
|
Olema Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-1968.561%
|
|
Bio-Path Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Enlivex Therapeutics Ltd.
|
- USD
|
-Infinity%
|
|
CollPlant Biotechnologies Ltd.
|
10.95 Million USD
|
96.779%
|
|
scPharmaceuticals Inc.
|
13.59 Million USD
|
97.403%
|
|
HilleVax, Inc.
|
- USD
|
-Infinity%
|
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
81.042%
|
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
|
Genprex, Inc.
|
- USD
|
-Infinity%
|
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
|
Immunic, Inc.
|
- USD
|
-Infinity%
|
|
Atossa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Aptorum Group Limited
|
431.37 Thousand USD
|
18.169%
|
|
Soleno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
|
OKYO Pharma Limited
|
- USD
|
-Infinity%
|
|
Carmell Therapeutics Corporation
|
- USD
|
-Infinity%
|
|
Achieve Life Sciences, Inc.
|
- USD
|
-Infinity%
|
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
|
Amicus Therapeutics, Inc.
|
399.35 Million USD
|
99.912%
|
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
bluebird bio, Inc.
|
29.49 Million USD
|
98.803%
|
|
DBV Technologies S.A.
|
15.72 Million USD
|
97.756%
|
|
Compugen Ltd.
|
33.45 Million USD
|
98.945%
|
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
4.044%
|
|
Vincerx Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
95.591%
|
|
Sensei Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Orchestra BioMed Holdings, Inc.
|
2.76 Million USD
|
87.21%
|
|
Zevra Therapeutics, Inc.
|
27.46 Million USD
|
98.715%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Benitec Biopharma Inc.
|
216 Thousand USD
|
-63.426%
|
|
Spyre Therapeutics, Inc.
|
886 Thousand USD
|
60.158%
|
|
Adicet Bio, Inc.
|
- USD
|
-Infinity%
|
|
Prime Medicine, Inc.
|
- USD
|
-Infinity%
|
|
Aditxt, Inc.
|
645.17 Thousand USD
|
45.286%
|
|
Madrigal Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
|
Quantum-Si incorporated
|
1.08 Million USD
|
67.375%
|
|
GlycoMimetics, Inc.
|
10 Thousand USD
|
-3430.0%
|
|
PolyPid Ltd.
|
- USD
|
-Infinity%
|
|
Aileron Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Invivyd, Inc.
|
- USD
|
-Infinity%
|
|
Quoin Pharmaceuticals, Ltd.
|
- USD
|
-Infinity%
|
|
Rigel Pharmaceuticals, Inc.
|
116.88 Million USD
|
99.698%
|
|
CorMedix Inc.
|
- USD
|
-Infinity%
|
|
Instil Bio, Inc.
|
- USD
|
-Infinity%
|
|
Recursion Pharmaceuticals, Inc.
|
44.57 Million USD
|
99.208%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
50 Million USD
|
99.294%
|
|
Finch Therapeutics Group, Inc.
|
107 Thousand USD
|
-229.907%
|
|
Spero Therapeutics, Inc.
|
96.73 Million USD
|
99.635%
|
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
|
AbCellera Biologics Inc.
|
38.02 Million USD
|
99.072%
|
|
Ocular Therapeutix, Inc.
|
58.44 Million USD
|
99.396%
|
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
|
Janux Therapeutics, Inc.
|
8.08 Million USD
|
95.633%
|
|
Verona Pharma plc
|
- USD
|
-Infinity%
|
|
Terns Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Vir Biotechnology, Inc.
|
86.18 Million USD
|
99.59%
|
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-382.821%
|
|
Verve Therapeutics, Inc.
|
11.75 Million USD
|
96.998%
|
|
Shattuck Labs, Inc.
|
1.65 Million USD
|
78.696%
|
|
AlloVir, Inc.
|
- USD
|
-Infinity%
|
|
BioVie Inc.
|
- USD
|
-Infinity%
|
|
Codexis, Inc.
|
70.14 Million USD
|
99.497%
|
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-56.051%
|
|
Agenus Inc.
|
156.31 Million USD
|
99.774%
|
|
Virax Biolabs Group Limited
|
156.41 Thousand USD
|
-125.676%
|
|
Lantern Pharma Inc.
|
- USD
|
-Infinity%
|
|
Viridian Therapeutics, Inc.
|
314 Thousand USD
|
-12.42%
|
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Immix Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
Celcuity Inc.
|
- USD
|
-Infinity%
|
|
Cardiff Oncology, Inc.
|
488 Thousand USD
|
27.664%
|
|
Acumen Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
IN8bio, Inc.
|
- USD
|
-Infinity%
|
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Trevi Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Lexicon Pharmaceuticals, Inc.
|
1.2 Million USD
|
70.681%
|
|
Liquidia Corporation
|
17.48 Million USD
|
97.981%
|
|
Quantum-Si incorporated
|
1.08 Million USD
|
67.375%
|
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
|
Xenon Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
Sol-Gel Technologies Ltd.
|
1.55 Million USD
|
77.284%
|
|
United Therapeutics Corporation
|
2.32 Billion USD
|
99.985%
|
|
Solid Biosciences Inc.
|
- USD
|
-Infinity%
|
|
Immuneering Corporation
|
- USD
|
-Infinity%
|
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
|
uniQure N.V.
|
15.84 Million USD
|
97.772%
|
|
Xilio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Enveric Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Poseida Therapeutics, Inc.
|
64.7 Million USD
|
99.454%
|
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
PMV Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Elevai Labs, Inc. Common Stock
|
1.71 Million USD
|
79.388%
|
|
Cue Biopharma, Inc.
|
5.49 Million USD
|
93.57%
|
|
Nuvectis Pharma, Inc.
|
- USD
|
-Infinity%
|
|
ARS Pharmaceuticals, Inc.
|
30 Thousand USD
|
-1076.667%
|
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
|
Forte Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Elevation Oncology, Inc.
|
- USD
|
-Infinity%
|
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
|
Immunome, Inc.
|
14.01 Million USD
|
97.482%
|
|
Compass Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
enGene Holdings Inc. Warrants
|
- USD
|
-Infinity%
|
|
Inovio Pharmaceuticals, Inc.
|
832.01 Thousand USD
|
57.573%
|
|
LENZ Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Altimmune, Inc.
|
426 Thousand USD
|
17.136%
|
|
Milestone Pharmaceuticals Inc.
|
1 Million USD
|
64.7%
|
|
Rallybio Corporation
|
- USD
|
-Infinity%
|
|
Plus Therapeutics, Inc.
|
4.91 Million USD
|
92.815%
|
|
Dianthus Therapeutics, Inc.
|
2.82 Million USD
|
87.509%
|
|
Moolec Science SA
|
905.04 Thousand USD
|
60.997%
|
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
|
Tourmaline Bio, Inc.
|
- USD
|
-Infinity%
|
|
NeurAxis, Inc.
|
2.46 Million USD
|
85.651%
|
|
Maravai LifeSciences Holdings, Inc.
|
288.94 Million USD
|
99.878%
|
|
Lumos Pharma, Inc.
|
2.05 Million USD
|
82.789%
|
|
enGene Holdings Inc. Common Stock
|
- USD
|
-Infinity%
|
|
180 Life Sciences Corp.
|
- USD
|
-Infinity%
|
|
NKGen Biotech, Inc. Warrants
|
- USD
|
-Infinity%
|
|
Opiant Pharmaceuticals, Inc.
|
40.72 Million USD
|
99.133%
|
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
Nutriband Inc.
|
2.08 Million USD
|
83.072%
|
|
CG Oncology, Inc. Common stock
|
204 Thousand USD
|
-73.039%
|
|
argenx SE
|
1.22 Billion USD
|
99.971%
|
|
Neurogene Inc.
|
- USD
|
-Infinity%
|
|
Mirum Pharmaceuticals, Inc.
|
186.37 Million USD
|
99.811%
|
|
Kintara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
CervoMed Inc.
|
7.14 Million USD
|
95.059%
|
|
CARGO Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Sesen Bio, Inc.
|
40 Million USD
|
99.118%
|
|
AnaptysBio, Inc.
|
17.15 Million USD
|
97.943%
|
|
Design Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Leap Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Seelos Therapeutics, Inc.
|
2.2 Million USD
|
83.976%
|
|
Achilles Therapeutics plc
|
- USD
|
-Infinity%
|
|
NeuroSense Therapeutics Ltd.
|
- USD
|
-Infinity%
|
|
ORIC Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Fractyl Health, Inc. Common Stock
|
120 Thousand USD
|
-194.167%
|
|
Rani Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
|
MoonLake Immunotherapeutics
|
- USD
|
-Infinity%
|
|
Palisade Bio, Inc.
|
250 Thousand USD
|
-41.2%
|
|
Beam Therapeutics Inc.
|
377.7 Million USD
|
99.907%
|
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
|
Enliven Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Kiora Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Iovance Biotherapeutics, Inc.
|
1.18 Million USD
|
70.311%
|
|
Taysha Gene Therapies, Inc.
|
15.45 Million USD
|
97.715%
|
|
Athira Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Vaccinex, Inc.
|
570 Thousand USD
|
38.07%
|
|
HCW Biologics Inc.
|
2.84 Million USD
|
87.578%
|
|
XOMA Corporation
|
4.75 Million USD
|
92.581%
|
|
Nektar Therapeutics
|
90.12 Million USD
|
99.608%
|
|
Arvinas, Inc.
|
78.5 Million USD
|
99.55%
|
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
|
Merus N.V.
|
43.94 Million USD
|
99.197%
|
|
Omega Therapeutics, Inc.
|
3.09 Million USD
|
88.591%
|
|
Quince Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Rezolute, Inc.
|
- USD
|
-Infinity%
|
|
Clene Inc.
|
654 Thousand USD
|
46.024%
|
|
Indaptus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
BeyondSpring Inc.
|
1.75 Million USD
|
79.84%
|
|
Synlogic, Inc.
|
3.37 Million USD
|
89.528%
|
|
Allarity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Phio Pharmaceuticals Corp.
|
- USD
|
-Infinity%
|
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
4.044%
|
|
Werewolf Therapeutics, Inc.
|
19.94 Million USD
|
98.23%
|
|
Krystal Biotech, Inc.
|
50.69 Million USD
|
99.304%
|
|
Karyopharm Therapeutics Inc.
|
146.03 Million USD
|
99.758%
|
|
SpringWorks Therapeutics, Inc.
|
5.44 Million USD
|
93.519%
|
|
Lipella Pharmaceuticals Inc.
|
449.61 Thousand USD
|
21.489%
|
|
MannKind Corporation
|
198.96 Million USD
|
99.823%
|
|
Ikena Oncology, Inc.
|
9.16 Million USD
|
96.146%
|
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Gyre Therapeutics, Inc.
|
113.45 Million USD
|
99.689%
|
|
Gossamer Bio, Inc.
|
- USD
|
-Infinity%
|
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
|
Cognition Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Legend Biotech Corporation
|
285.14 Million USD
|
99.876%
|
|
Mural Oncology plc
|
- USD
|
-Infinity%
|
|
Biora Therapeutics, Inc.
|
4000.00 USD
|
-8725.0%
|
|
PaxMedica, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Disc Medicine, Inc.
|
- USD
|
-Infinity%
|
|
Champions Oncology, Inc.
|
50.15 Million USD
|
99.296%
|
|
REGENXBIO Inc.
|
90.24 Million USD
|
99.609%
|
|
Ensysce Biosciences, Inc.
|
2.23 Million USD
|
84.174%
|
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
|
Cellectar Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Edgewise Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Vaxart, Inc.
|
7.37 Million USD
|
95.216%
|
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
|
Aldeyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Cellectis S.A.
|
755 Thousand USD
|
53.245%
|
|
Longeveron Inc.
|
709 Thousand USD
|
50.212%
|
|
Repare Therapeutics Inc.
|
51.13 Million USD
|
99.31%
|
|
Sarepta Therapeutics, Inc.
|
1.24 Billion USD
|
99.972%
|
|
Inozyme Pharma, Inc.
|
- USD
|
-Infinity%
|
|
Revolution Medicines, Inc.
|
11.58 Million USD
|
96.952%
|
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
|
Third Harmonic Bio, Inc.
|
- USD
|
-Infinity%
|
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Anixa Biosciences, Inc.
|
210 Thousand USD
|
-68.095%
|
|
Vertex Pharmaceuticals Incorporated
|
9.86 Billion USD
|
99.996%
|
|
Denali Therapeutics Inc.
|
330.53 Million USD
|
99.893%
|
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Veru Inc.
|
16.29 Million USD
|
97.834%
|
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
|
Passage Bio, Inc.
|
- USD
|
-Infinity%
|
|
Context Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Exicure, Inc.
|
- USD
|
-Infinity%
|
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
86.94%
|
|
Revolution Medicines, Inc. Warrant
|
11.58 Million USD
|
96.952%
|
|
Scinai Immunotherapeutics Ltd.
|
- USD
|
-Infinity%
|
|
Rhythm Pharmaceuticals, Inc.
|
77.42 Million USD
|
99.544%
|
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
|
ABVC BioPharma, Inc.
|
152.43 Thousand USD
|
-131.582%
|
|
Carisma Therapeutics, Inc.
|
14.91 Million USD
|
97.634%
|
|
Unicycive Therapeutics, Inc.
|
675 Thousand USD
|
47.704%
|
|
OmniAb, Inc.
|
34.16 Million USD
|
98.967%
|
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
|
Fennec Pharmaceuticals Inc.
|
21.25 Million USD
|
98.339%
|
|
Lipocine Inc.
|
-2.85 Million USD
|
112.382%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Nautilus Biotechnology, Inc.
|
- USD
|
-Infinity%
|
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
84.234%
|
|
G1 Therapeutics, Inc.
|
82.51 Million USD
|
99.572%
|
|
Bellerophon Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Sage Therapeutics, Inc.
|
86.45 Million USD
|
99.592%
|
|
Ocugen, Inc.
|
6.03 Million USD
|
94.152%
|
|
Mind Medicine (MindMed) Inc.
|
- USD
|
-Infinity%
|
|
Q32 Bio Inc.
|
1.15 Million USD
|
69.464%
|
|
Brainstorm Cell Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Alumis Inc. Common Stock
|
- USD
|
-Infinity%
|
|
Equillium, Inc.
|
36.08 Million USD
|
99.022%
|
|
Kyverna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Coya Therapeutics, Inc.
|
6 Million USD
|
94.119%
|
|
CNS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
|
Galera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
Evelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
|
Comera Life Sciences Holdings, Inc.
|
633.1 Thousand USD
|
44.243%
|
|
Dominari Holdings Inc.
|
2.03 Million USD
|
82.688%
|
|
Edesa Biotech, Inc.
|
- USD
|
-Infinity%
|
|
vTv Therapeutics Inc.
|
- USD
|
-Infinity%
|
|
Bio-Techne Corporation
|
1.15 Billion USD
|
99.97%
|
|
Agios Pharmaceuticals, Inc.
|
26.82 Million USD
|
98.684%
|
|
Harmony Biosciences Holdings, Inc.
|
582.02 Million USD
|
99.939%
|
|
Prelude Therapeutics Incorporated
|
- USD
|
-Infinity%
|
|
Candel Therapeutics, Inc.
|
- USD
|
-Infinity%
|
|
iTeos Therapeutics, Inc.
|
12.59 Million USD
|
97.197%
|
|
Nkarta, Inc.
|
- USD
|
-Infinity%
|
|
BioCardia, Inc.
|
477 Thousand USD
|
25.996%
|
|
Iterum Therapeutics plc
|
- USD
|
-Infinity%
|
